Cough Tracker App: Revolutionary AI-powered cough detection App to predict asthma crisis

1

US National Academy of Medicine Grand Award 2020 Winner for the most disruptive technologies

2

Rapid growth: 1,000 users in the first month after launch despite close to no marketing efforts

3

Target Audience: patients with cough-related diseases such as COVID-19, ASTHMA, FLU, COPD, etc.

4

Market size: COVID-19 (220M people), FLU (800M), ASTHMA (400M), COPD (220M)

5

Scaling potential: up to 30% of all health-related costs are related to respiratory diseases

6

96% Cough detection Accuracy validated with independent healthcare experts

7

Seed-funded twice and granted by the US National Academy of Medicine

About 10% of the world's population suffers from asthma. Our teammate suffers from an exhausting asthma night cough. We know first-hand that current healthcare is not designed to help patients on a daily basis. So we decided to leverage our expertise in AI and digital biomarkers and created the first-in-class app for respiratory patients.

Cough Tracker App

Revolutionary AI-powered cough detection App to predict asthma crisis

Highlights

Our Team

Pitch

Downloads